- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 204
Hopin hatches $450m series D plan
Salesforce and Slack were among a consortium of new and existing backers for Hopin’s series D round, which comes only five months after a $400m series C.
Aug 6, 2021Deere undertakes Bear Flag purchase
John Deere is paying $250m to buy the AgFunder-backed self-driving tractor system developer.
Aug 6, 2021MindTickle wins $100m at $1.2bn valuation
The sales training software developer has now raised $281m in total, with SoftBank and Qualcomm returning for its series E round.
Aug 6, 2021Joinn Biologics enters $150m series B
The China Union-backed drug contract manufacturer has raised the funding approximately a year and a half after a $60m series A.
Aug 6, 2021Best Buy commits $10m to BIPOC firm
Best Buy also plans to work together with Brown Venture Group to develop a stronger community of diverse suppliers and launch an entrepreneurial partnership programme.
Aug 6, 2021Trimble constructs $200m corporate venturing fund
The engineering technology provider’s newly formed Trimble Ventures unit will target startups and scale-ups working on technologies strategic to its existing industrial businesses.
Aug 5, 2021FullStory goes on with $103m series D
GV, Dell Technologies Capital and Salesforce Ventures have all returned to back the digital experience tracking service’s latest round, which valued it at $1.8bn.
Aug 5, 2021Bayer to buy Vividion for $1.5bn
Bayer is set to acquire the precision therapeutics developer backed by Alexandria Venture Investments, Celgene and SoftBank, with another $500m in milestone payments up for grabs.
Aug 5, 2021Sonoma captures $265m in series B
Osage University Partners has backed the immunotherapy developer in a series B round, which took its overall funding to over $335m.
Aug 5, 2021Sonoma captures $265m in series B
Alphabet, Eli Lilly, Dong-A ST and Alexandria Real Estate Equities backed the immunotherapy developer in a series B round, which took its overall funding to over $335m.
Aug 5, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


